anti-MART-1 TCR retroviral vector-transduced autologous TIL
Term · Oncology and biomedicine · MLC-T-ONC-010877
Human tumor infiltrating lymphocytes (TIL) isolated from a melanoma patient and were engineered to react with the melanoma antigen MART-1 (Melanoma Antigen Recognized by T cells, also called Melan-A). These TILs are transfected with a retroviral vector encoding anti-MART-1 specific T-cell receptors, grown in culture, and then transferred back to the patient. These genetically modified TIL may recognize and halt the growth of MART-1-expressing melanoma cells.
| Identifier | MLC-T-ONC-010877 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | MSGV1AIB (anti-MART-1 TCR) retroviral vector-transduced autologous TIL |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010877",
"term": "anti-MART-1 TCR retroviral vector-transduced autologous TIL",
"field": "Oncology and biomedicine",
"definition": "Human tumor infiltrating lymphocytes (TIL) isolated from a melanoma patient and were engineered to react with the melanoma antigen MART-1 (Melanoma Antigen Recognized by T cells, also called Melan-A). These TILs are transfected with a retroviral vector encoding anti-MART-1 specific T-cell receptors, grown in culture, and then transferred back to the patient. These genetically modified TIL may recognize and halt the growth of MART-1-expressing melanoma cells.",
"synonyms": [
"MSGV1AIB (anti-MART-1 TCR) retroviral vector-transduced autologous TIL"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-mart-1-tcr-retroviral-vector-transduced-autologous-til/"
}
Record 1,995 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.